SCHEMBL26974367

SCHEMBL26974367

Cc1ccc(C(=O)N/N=C/c2cc(C)cc(Br)c2O)c(F)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 5/20 0.67
SIRT1 Q96EB6 4/20 0.57
MAPT P10636 6/20 0.47
NPC1 O15118 3/20 0.47
KDM4E B2RXH2 3/20 0.47
LMNA P02545 3/20 0.47
RAB9A P51151 3/20 0.47
HTT P42858 2/20 0.47
ALPL P05186 1/20 0.47
GLA P06280 1/20 0.47
ALPI P09923 1/20 0.47
ALPG P10696 1/20 0.47
FTO Q9C0B1 1/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPK1 P28482 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
PKM P14618 1/20 0.46
SAE1 Q9UBE0 1/20 0.46
UBA2 Q9UBT2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26974401 0.92 PIK3CG (0.79) PIK3CGSIRT1MAPTNPC1KDM4E
SCHEMBL26974370 0.84 PIK3CG (0.66) PIK3CGMAPTNPC1KDM4ELMNA
SCHEMBL684876 0.83 PIK3CG (0.84) PIK3CGSIRT1MAPTNPC1KDM4E
SCHEMBL26974376 0.82 SIRT1 (0.83) PIK3CGSIRT1MAPTNPC1KDM4E
SCHEMBL26974400 0.81 PIK3CG (0.80) PIK3CGMAPTNPC1KDM4ELMNA
SCHEMBL26974365 0.81 PIK3CG (0.60) PIK3CGSIRT1MAPTNPC1KDM4E
SCHEMBL684745 0.80 PIK3CG (0.83) PIK3CGSIRT1MAPTNPC1KDM4E
SCHEMBL26974385 0.80 PIK3CG (0.58) PIK3CGSIRT1MAPTNPC1KDM4E
SCHEMBL684801 0.78 PIK3CG (0.79) PIK3CGSIRT1MAPTNPC1KDM4E
SCHEMBL26974380 0.77 SIRT1 (0.67) PIK3CGSIRT1MAPTNPC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858880-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2024-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11858880-B2 Anti-fungals compounds targeting the synthesis of fungal sphingolipids ERG28, UGCG, DPM1 PIK3CG 488/4885SIRT1 2412/4885MAPT 2146/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.